Global Clinical Trial Landscape – Focus On Asia Pacific

whitePaper | January 17, 2020

Value-based reimbursement (VBR) models are becoming more common. Success under these models depends on showing positive improvement in key metrics, but providers often struggle to accurately report the quality of care provided. A next-generation revenue cycle that combines clinically aware artificial intelligence (AI) with an unmatched foundation of evidence-based medical research and knowledge provides the transparency necessary to both accurately report care quality and directly influence the patient satisfaction quality metric. This paper reviews how a well-tuned revenue cycle can help hospitals succeed with value-based contracts, earning appropriate incentives and avoiding penalties.

whitePaper | January 13, 2023

The COVID-19 pandemic and response measures presented many hardships to people living in Sub-Saharan Africa.

whitePaper | November 10, 2022

Woman’s Hospital is a specialty hospital that primarily serves women and infants in Baton Rouge, La., and the surrounding regions.

whitePaper | March 10, 2023

The healthcare industry has widely acknowledged that the more we understand a patient’s unique healthcare journey the greater the chance we have at a positive health outcome. How does that concept tie in to real-word data (RWD)?

whitePaper | September 21, 2022

Prior to 2020, the answer was likely not very much. Although decentralized trials (DCT) existed prior to the pandemic, COVID-19 undoubtedly had a large impact on the rapid adoption of DCT technologies.

whitePaper | December 30, 2022

Every employer needs to provide their employee health plan members with access to providers when the member is away from home or when they need access to a specialist that isn’t available in their primary network.